Galapagos NV
GLPG
#5071
Rank
$1.86 B
Marketcap
$27.73
Share price
0.00%
Change (1 day)
-9.05%
Change (1 year)

Galapagos NV (GLPG) - P/B ratio

P/B ratio as of July 2026 : 0.4946

According to Galapagos NV's latest financial reports the company has a price-to-book ratio of 1.51879.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Galapagos NV - P/B ratio (from 2008 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-310.5716-4.22%
2024-12-310.5968-31.15%
2023-12-310.8668-19.62%
2022-12-311.08-11.64%
2021-12-311.22-38.1%
2020-12-311.97-52.99%
2019-12-314.1916.07%
2018-12-313.61-8.65%
2017-12-313.965.92%
2016-12-313.73-39.55%
2015-12-316.18171.33%
2014-12-312.28-16.16%
2013-12-312.72-24.72%
2012-12-313.6155.46%
2011-12-312.327.73%
2010-12-312.1531.8%
2009-12-311.6387.45%
2008-12-310.8717

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.61 1,438.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.10 527.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-65.8-13,399.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.23 148.93%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6.63 1,240.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.64 1,040.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
4.57 823.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
1.67 236.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.67 845.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel